What does the Pulmonary to Systemic (P/AF) ratio indicate regarding heart or lung problems?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

P/F Ratio vs Qp:Qs Ratio: Distinguishing Lung from Heart Problems

The question appears to conflate two different ratios: the P/F ratio (PaO2/FiO2) assesses lung oxygenation function and does NOT distinguish heart from lung problems, while the Qp:Qs ratio (pulmonary-to-systemic blood flow ratio) identifies cardiac shunts and is used specifically in congenital heart disease evaluation.

Understanding the P/F Ratio (PaO2/FiO2)

The P/F ratio measures lung oxygenation capacity only and cannot differentiate cardiac from pulmonary pathology:

  • The P/F ratio is calculated as arterial oxygen tension (PaO2) divided by the fraction of inspired oxygen (FiO2) 1
  • This ratio is used primarily for classifying severity of acute respiratory distress syndrome (ARDS), with thresholds of ≤100 mmHg (severe), 101-200 mmHg (moderate), and 201-300 mmHg (mild) 1
  • In acute pulmonary embolism, a P/F ratio cut-off of 256.41 predicts intermediate-high and high-risk patients with 74.2% sensitivity and 81.6% specificity 2
  • The P/F ratio reflects gas exchange efficiency but does not distinguish whether hypoxemia originates from primary lung disease versus cardiac causes 2, 1

Understanding the Qp:Qs Ratio (Pulmonary-to-Systemic Flow)

The Qp:Qs ratio specifically identifies and quantifies cardiac shunts:

  • A hemodynamically significant intracardiac shunt is defined as Qp:Qs ≥1.5:1 with evidence of chamber enlargement distal to the shunt 3
  • This ratio is measured during right heart catheterization and represents the ratio of pulmonary blood flow (Qp) to systemic blood flow (Qs) 3
  • Qp:Qs >1.5:1 indicates left-to-right shunting (systemic-to-pulmonary), suggesting congenital heart disease such as atrial septal defect or ventricular septal defect 3
  • In Eisenmenger syndrome, the shunt reverses to pulmonary-to-systemic (or bidirectional) when pulmonary vascular resistance becomes severely elevated 3

PA:Ao Ratio for Pulmonary Hypertension Detection

If you're asking about distinguishing pulmonary vascular disease from other causes, the PA:Ao ratio (pulmonary artery to aorta diameter ratio) is relevant:

  • PA:Ao ratio >0.83 predicts moderate/severe pulmonary hypertension in heart failure with preserved ejection fraction with good correlation (r=0.421, p<0.001) 4
  • PA:Ao ratio >1.0 has 70% sensitivity and 92% specificity for detecting pulmonary arterial hypertension (mean PAP >20 mmHg) in patients under 50 years old 5
  • This ratio helps identify pulmonary vascular disease but does not distinguish primary lung disease (Group 3 PH) from cardiac causes (Group 2 PH) 4, 6

Clinical Algorithm for Heart vs Lung Differentiation

To distinguish cardiac from pulmonary causes of respiratory compromise, you need:

  1. Right heart catheterization with measurement of:

    • Pulmonary artery wedge pressure (PAWP): PAWP >15 mmHg indicates post-capillary (cardiac) PH; PAWP ≤15 mmHg indicates pre-capillary (lung/vascular) PH 3, 7
    • Transpulmonary gradient (TPG = mean PAP - mean PCWP): TPG >12 mmHg suggests reactive pulmonary vascular disease 8
    • Qp:Qs ratio: ≥1.5:1 indicates significant cardiac shunt 3
  2. Imaging assessment:

    • Echocardiography for chamber enlargement and shunt detection 3
    • CT for PA:Ao ratio if pulmonary hypertension suspected 4, 5

Critical Pitfall

The P/F ratio alone cannot distinguish heart from lung problems - it only quantifies oxygenation impairment regardless of etiology. You must use hemodynamic measurements (PAWP, TPG, Qp:Qs) obtained during right heart catheterization to make this distinction 3, 8, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2015

Research

Ratio of pulmonary artery diameter to ascending aortic diameter and severity of heart failure.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2018

Guideline

Hemodynamic Measurements in Pulmonary Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Transpulmonary Gradient Measurement and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.